Thanks Jeff, and good afternoon, everyone. For those of you who know me or have listened to our conference calls, have heard me say the proof is in the numbers. That is especially true this quarter. We demonstrated during the quarter that we have and will continue to execute against our stated strategy to grow annual revenue at a double-digit pace, somewhere between 10 to 20% and grow profitability even faster. This allows us to generate more cash and return more capital to shareholders. The hard work of the past two years to position ReposiTrak as the go-to source to address the track and trace opportunity while simultaneously growing all lines of business has not been easy to say the least. And by no means we are claiming mission accomplished. We have plenty more work to do. Remember, we had to make many tough decisions along the way in order to efficiently allocate resources to grow our network. Some of those decisions were not popular with investors like sunsetting products and services and walking away from high touch, low opportunity revenue to make room for growth. However, the proof is in the numbers and the results we are reporting for the quarter and year-to-date are reflected in growth in top line and bottom line and the KPIs in between. Previously in the second fiscal quarter, we pointed out that our deferred revenue has increased 70% to $4.2 million. As most of you know, deferred revenue is an indicator of future revenue yet to be recognized. Our contracted revenue, and hence deferred revenue, is comprised of all of our solutions, not just traceability. The services are provided in accordance with the contract that earned revenue will be layered in over the subsequent 12 months. As you can see by our revenue growth that earned revenue is accelerating. Revenue grew 16% in the third fiscal quarter to $5.9 million, and we continue to carry a meaningful amount of deferred revenue on our balance sheet, $3.7 million as of March 31. These contracts will be converted to recognized revenue over the next 12 to 15 months, and obviously we're adding more and more contracts every week. What you see today is just a portion of the growth we expect over the next few years. As a result, Randy and I are confident that ReposiTrak will continue to deliver on our goal of growing annual top line revenue at a double-digit clip. Be clear, we are not a quarterly company. Some quarters may be higher or lower than others. However, we are more confident today than ever before that our goal to grow annual top line revenue by 10% to 20% is here to stay for the foreseeable future. While traceability is accelerating, grabbing headlines and serving as the current catalyst, we are experiencing growth in all lines of business, traceability, compliance, and supply chain. While traditional sales of one service to solve, one customer problem continues to grow. Our cross-selling initiatives are gaining momentum for obvious reasons. Why we have an end-to-end solution. So once we receive customer data and they're successful on one solution, they recognize why not expand to another. Yes, increased, but measured growth is important, but in my view, generating earnings and cash is the ultimate focus. Why? In the third quarter, we translated 16% revenue growth into 27% net income growth. But another way, we converted $828,000 in incremental revenue into $415,000 in incremental net income. That's GAAP net income, not adjusted EBITDA or some other qualified metric. So $0.50 of every incremental revenue dollar fell to the bottom line. Those results reflect the increased cost for investments in marketing, technology, and onboarding of new customers that we believe will flatten over time. Currently, our revenue contribution margin above fixed cost is about 50%, but our goal is to get closer to 80%. As many of you have heard me say time and time again, it takes $12 million in cash to run this place. Our goal is to deliver $0.70 to $0.80 profit on every dollar of incremental revenue over the annual $12 million in cash costs. That is cash costs, excluding stock compensation expense, bad debt, depreciation, amortization, and other non-cash accounting costs. That's the goal, but we ain't there yet. Again, our strategy is simple. First, take exceptional care of the customer. Second, execute flawlessly, grow recurring revenue, balancing cost with opportunity, increase profitability, use cash to buy back common stock, redeem the preferred, and do it all with no bank debt. At the same time, return capital to shareholders through an increasing cash dividend. Third, we continue to build cash on the balance sheet over $28 million as of March 31, 2025. Let's get to the numbers. Total revenue for the third quarter fiscal 2025 was up 16% to $5.9 million versus $5.1 million in the prior year. Recurring revenue increased 15% to $5.8 million. The percentage of recurring to total revenue declined from 99% to 98% due to an acceleration of customer onboarding and the one-time setup fees associated with them. Operating expense increased 7% reflecting our ongoing investment in RTN, higher commissions due to higher revenue and increases in insurance and benefit costs for employees. Cost of revenue increased 10% due to investment in developer resources to further expand our wizard, a proprietary self-implementing platform to allow suppliers to onboard with little or no human interaction. Sales and marketing increase 4% due to continued investment and awareness of our solution suite of traceability, supply chain and compliance. As awareness increases, we believe our marketing spend to educate the industry will flatten out over time. G&A increased 8%, this increase reflects increases in company benefits for employees and other insurance costs incurred during the quarter. Depreciation and amortization increased 14% due to leased equipment for a newest data center located at Switch Reno, Nevada. Switch Reno compliments our main data center located at Switch Las Vegas and eliminates our corporate headquarters data center in Utah. Income from operations increased 43% from $1.3 million to $1.8 million. GAAP net income increased from $1.6 million to $2 million up 27%. GAAP net income to shareholders increased from $1.4 million to $1.9 million, up 33%. Earnings per share basic and diluted was $0.10 per share. This compares to $0.8 per basic and diluted share last year. Cash is $28.1 million at the end of the March 31 quarter. Keep in mind, the cash balance is net of the more than $25 million in capital we've returned to shareholders through a common stock cash dividend that has increased 20% since inception. It also includes the redemption of half of the preferred thus far, buying back 2.2 million common shares and paying off over $6 million in bank debt since we instituted our capital allocation strategy only a few short years ago. Turning to the fiscal year to date numbers, total revenue increased 10.3%, $16.8 million versus $15.3 million. Recurring revenue increased 9% to $16.6 million. Total operating expenses for the fiscal year to date were up 6% due to investments in RTN, increased insurance and employee benefit costs and investment in development of Wizard Tools. SG&A costs were up $419,000 or 5% due to investment in our growth. Fiscal year to date, income from operations was up 25%, $4.6 million versus $3.7 million. Net income to common shareholders increased 24% from $4 million to $4.9 million. Earnings per share for the fiscal year to date was $0.27 per basic share and $0.26 per diluted share. This is based on 18.2 million basic shares outstanding and 19.1 million shares diluted respectively an increase in EPS of over 22%. We remain confident that our continued revenue growth will double our historical $20 million annual revenue over the next several years, deliver at least 80% gross margins and 30% net margins. If we are successful, this will translate into higher earnings per share and significant cash generation. Turning to our capital allocation plan, over the first nine months of the fiscal year, $3.7 million has been returned to shareholders in the form of cash dividends, common stock repurchases, and preferred stock redemptions since inception, we redeemed $4.6 million in preferred stock with roughly $4.2 million to go. At our continued pace of redemption, the preferred stock will be paid off on or before September, 2027. As I have said before, the board will evaluate our capital allocation strategy, making appropriate adjustments based on the approach most beneficial to shareholders at that time. Our goal is to continue to return 50% of annual cash from operations to shareholders and putting the other half in the bank. In summary, our strategy has not changed. Deliver flawless execution for our customers. When the customer's successful, they grow and we grow. Grow recurring revenue balance cost with opportunity, continue to increase profitability, EPS and cash return more and more capital to shareholders. Yes, it's really that simple and proof will be in the numbers. That's all I have today. Thanks everyone for your time. At this point, I'll pass the call over to Randy. Randy?